Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 1, 2026

Modified Radical Neck Dissection for Cervical Metastasis
06:05

Modified Radical Neck Dissection for Cervical Metastasis

Published on: February 20, 2026

Elective neck dissection for second primary after previous definitive radiotherapy.

Aaron D Falchook1, Roi Dagan, Christopher G Morris

  • 1Department of Radiation Oncology at the University of Florida College of Medicine, Gainesville, FL, USA

American Journal of Otolaryngology
|June 11, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustained Locoregional Control With Deintensified Chemoradiotherapy for HPV Oropharyngeal Carcinoma.

JAMA otolaryngology-- head & neck surgery·2026
Same author

Ten-year outcomes for image-guided moderately hypofractionated proton therapy for prostate cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Long-Term Outcomes of Consolidative Proton Therapy for Pediatric Classical Hodgkin Lymphoma.

International journal of particle therapy·2026
Same author

Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial.

Lancet (London, England)·2025
Same author

RBE-Guided Treatment Planning, LET Optimization, and Implications of Proton Arc Therapy for the Sparing of Nervous Tissue in Head and Neck Proton Therapy.

Cancers·2025
Same author

A Systematic Study on Local Failure Events Post Chemoradiation Therapy for Cervical Cancer: Understanding the Impact of Baseline Lateral Anatomic Compartment Involvement.

International journal of radiation oncology, biology, physics·2025

For patients with a second head and neck cancer, elective neck dissection may be safely omitted. This approach can maintain treatment efficacy while reducing patient morbidity from surgery.

Area of Science:

  • Oncology
  • Head and Neck Surgery
  • Radiation Oncology

Background:

  • Patients with prior head and neck squamous cell carcinoma (SCCHN) treated with radiotherapy and elective nodal irradiation may develop a second primary SCCHN.
  • The role of neck dissection in managing these second primary tumors requires clarification.

Purpose of the Study:

  • To evaluate the necessity and impact of elective neck dissection (END) in patients with a second primary SCCHN after prior treatment for an initial SCCHN.
  • To assess the risk of occult nodal disease and the associated morbidity.

Main Methods:

  • Retrospective review of 13 patients with metachronous SCCHN treated with surgery for the second primary.
  • Analysis of outcomes for patients who underwent END (n=10) versus those who did not.

More Related Videos

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy
05:25

Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy

Published on: October 24, 2025

Related Experiment Videos

Last Updated: Jun 1, 2026

Modified Radical Neck Dissection for Cervical Metastasis
06:05

Modified Radical Neck Dissection for Cervical Metastasis

Published on: February 20, 2026

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy
05:25

Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy

Published on: October 24, 2025

Main Results:

  • Only 1 of 10 neck dissection specimens showed metastatic disease (8% incidence).
  • Five-year outcomes included 67% local-regional control and 77% cause-specific survival.
  • Complications (grade 2+) occurred exclusively in patients who received END.

Conclusions:

  • The risk of occult nodal metastasis appears low in selected patients with a second primary SCCHN.
  • Omitting END may reduce patient morbidity without compromising treatment efficacy.
  • Further research with larger cohorts is warranted to confirm these findings.